Matthew Garza and Rhea Teng writing for Diatribe report that Wegovy, a once-weekly injectable medication (ric name: semaglutide), has been approved by the FDA to
JDRF Virtual event – Fusion, Type 1 technology and devices for adults on Saturday 26 June, 10am – 1.30pm. This event is open to any
Researchers at Staffordshire University have developed a low-cost method to help prevent foot ulcers in people with diabetes. Millions of people with the condition are
Researchers at the University of California San Diego School of Medicine have identified a predictive causal role for specific cell types in Type 1 diabetes
Dexcom has presented promising results from two studies of continuous glucose monitors, including its next-generation G7 CGM, reports Drug Delivery Business. The first study –
Shares of Precigen have increased after the company’s Phase 1b/2a study of its AG019 ActoBiotics, designed to address the underlying cause of Type 1 diabetes.
A lower carbohydrate diet is an effective short-term option for adults living with Type 2 diabetes and overweight or obesity, concludes a report by the
Spirit Pharmacy is the UK’s only home delivery pharmacy offering tailored services for people living with diabetes. Their mission is to make accessing advice, education,
NHS Chief Executive Sir Simon Stevens has announced a trial to support the wider roll-out of artificial pancreas technology across England for people with Type
Researchers at King’s College London are looking for older people with Type 2 diabetes or their carers who have recently started insulin treatment to take
